Jaime Merchan, MD, discusses the background and findings from the LITESPARK-013 trial of belzutifan for the treatment of patients with advanced clear cell renal cell carcinoma.

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

Infection in the abdomen and bleeding may also occur. Surgery is more challenging if the tumor extends to the inside of the renal vein, and often requires a surgeon who specializes in vascular disease ...

Oct 30 (Reuters) - The lowest dose of Novo Nordisk's (NOVOb.CO), opens new tab weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday. Several doses ...

A small tweak in the dosing regimen of Eli Lilly’s Alzheimer’s disease drug Kisunla has reduced brain swelling of patients in a trial, the company said Tuesday. In the phase 3 study ...

Rybelsus is an oral glucagon-like peptide-1 (GLP-1) agonist and sibling medication to Ozempic and Wegovy. Per a phase 3 trial, Rybelsus was found to reduce cardiovascular risk among patients with ...

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...

Low dose birth control pills may have fewer side effects compared with older, higher-dose ones, but certain groups may still have increased health risks. If they aren’t taken correctly ...

Kelowna, BC, October 25, 2024--(T-Net)--Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), a global innovator in drug delivery platforms announced that dosing has begun ... by Novo Nordisk® under ...

In its latest guidance, released Wednesday, the CDC recommends that adults aged 65 and older, as well as individuals with weakened immune systems, receive a second dose of the updated vaccine six ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) officially recommended.

Opens in a new tab or window The CDC's Advisory Committee on Immunization Practices (ACIP) on Thursday unanimously endorsed revising the dosing and interval of the meningococcal group B vaccine ...